Have your own idea? Try our Stock Screener
PeptiDream is up 7.4%, leading the way for the Biotech industry, which has gained 4.3%. In the same time, Takara Bio was down 5.2%. This takes the industry's 12 month performance to a gain of 25%. Looking forward, earnings are forecast to grow by 14% annually.
Has the Japanese Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 03 Dec 2024 | JP¥1.1t | JP¥207.2b | -JP¥12,080,899,000.00 | 22.8x | -92.5x | 5.4x |
Thu, 31 Oct 2024 | JP¥1.1t | JP¥214.3b | -JP¥3,941,502,000.00 | 22.6x | -279.5x | 5.1x |
Sat, 28 Sep 2024 | JP¥1.1t | JP¥214.3b | -JP¥2,078,229,000.00 | 22x | -552.8x | 5.4x |
Mon, 26 Aug 2024 | JP¥1.0t | JP¥210.1b | -JP¥580,439,000.00 | 14.2x | -1768.1x | 4.9x |
Wed, 24 Jul 2024 | JP¥1.1t | JP¥187.7b | -JP¥15,871,901,000.00 | 93.8x | -66.7x | 5.6x |
Fri, 21 Jun 2024 | JP¥904.7b | JP¥187.7b | -JP¥15,773,284,000.00 | 82.7x | -57.4x | 4.8x |
Sun, 19 May 2024 | JP¥769.6b | JP¥194.2b | -JP¥14,975,545,000.00 | 93.1x | -51.4x | 4x |
Tue, 16 Apr 2024 | JP¥738.7b | JP¥194.2b | -JP¥15,746,837,000.00 | 65.1x | -46.9x | 3.8x |
Thu, 14 Mar 2024 | JP¥776.8b | JP¥193.6b | -JP¥19,603,997,000.00 | 60.1x | -39.6x | 4x |
Sat, 10 Feb 2024 | JP¥747.3b | JP¥222.4b | -JP¥12,442,827,000.00 | 16.7x | -60.1x | 3.4x |
Mon, 08 Jan 2024 | JP¥802.9b | JP¥222.3b | -JP¥12,668,455,000.00 | 17.4x | -63.4x | 3.6x |
Wed, 06 Dec 2023 | JP¥779.0b | JP¥221.9b | -JP¥12,426,487,000.00 | 16.6x | -62.7x | 3.5x |
Fri, 03 Nov 2023 | JP¥746.6b | JP¥223.0b | -JP¥14,350,085,000.00 | 19.3x | -52x | 3.3x |
Sun, 01 Oct 2023 | JP¥847.8b | JP¥223.0b | -JP¥14,518,735,000.00 | 26.2x | -58.4x | 3.8x |
Tue, 29 Aug 2023 | JP¥910.1b | JP¥225.1b | -JP¥19,814,131,000.00 | 49.6x | -45.9x | 4x |
Thu, 27 Jul 2023 | JP¥918.9b | JP¥223.7b | -JP¥20,836,669,000.00 | 49.1x | -44.1x | 4.1x |
Sat, 24 Jun 2023 | JP¥973.0b | JP¥223.2b | -JP¥20,139,670,000.00 | 64.6x | -48.3x | 4.4x |
Mon, 22 May 2023 | JP¥915.5b | JP¥218.6b | -JP¥25,244,669,000.00 | 32.1x | -36.3x | 4.2x |
Wed, 19 Apr 2023 | JP¥959.7b | JP¥218.3b | -JP¥21,583,522,000.00 | 21.9x | -44.5x | 4.4x |
Fri, 17 Mar 2023 | JP¥902.5b | JP¥218.1b | -JP¥18,469,580,000.00 | 20.6x | -48.9x | 4.1x |
Sun, 12 Feb 2023 | JP¥957.1b | JP¥200.2b | -JP¥23,403,917,000.00 | 38.1x | -40.9x | 4.8x |
Tue, 10 Jan 2023 | JP¥907.3b | JP¥186.8b | -JP¥24,722,604,000.00 | 41.8x | -36.7x | 4.9x |
Thu, 08 Dec 2022 | JP¥897.7b | JP¥186.6b | -JP¥26,666,433,000.00 | 45.6x | -33.7x | 4.8x |
Sat, 05 Nov 2022 | JP¥813.4b | JP¥176.5b | -JP¥24,989,270,000.00 | 46.8x | -32.5x | 4.6x |
Mon, 03 Oct 2022 | JP¥852.9b | JP¥176.5b | -JP¥24,974,270,000.00 | 42.3x | -34.2x | 4.8x |
Wed, 31 Aug 2022 | JP¥950.4b | JP¥174.4b | -JP¥21,144,270,000.00 | 22x | -44.9x | 5.4x |
Fri, 29 Jul 2022 | JP¥970.6b | JP¥171.3b | -JP¥16,112,943,000.00 | 20.9x | -60.2x | 5.7x |
Sun, 26 Jun 2022 | JP¥879.1b | JP¥171.3b | -JP¥16,112,943,000.00 | 20.6x | -54.6x | 5.1x |
Tue, 24 May 2022 | JP¥943.1b | JP¥169.3b | -JP¥13,349,721,000.00 | 11.8x | -70.6x | 5.6x |
Thu, 21 Apr 2022 | JP¥1.0t | JP¥164.2b | -JP¥13,043,295,000.00 | 14.7x | -78.7x | 6.3x |
Sat, 19 Mar 2022 | JP¥1.1t | JP¥164.2b | -JP¥13,044,654,000.00 | 15.2x | -82.4x | 6.5x |
Mon, 14 Feb 2022 | JP¥1.0t | JP¥159.8b | -JP¥6,977,039,000.00 | 15.2x | -149.3x | 6.5x |
Wed, 12 Jan 2022 | JP¥1.2t | JP¥163.5b | -JP¥5,447,358,000.00 | 18.2x | -218.1x | 7.3x |
Fri, 10 Dec 2021 | JP¥1.3t | JP¥163.7b | -JP¥6,105,358,000.00 | 18.5x | -206.3x | 7.7x |
-206.3x
Which industries have driven the changes within the Japanese Healthcare industry?
JP Market | -0.49% | |
Healthcare | 1.17% | |
Biotech | 4.27% | |
Biotech | 4.27% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
2160 GNI Group | JP¥3.32k | 18.7% +JP¥26.2b | 3.3% | PE23.2x | |
4587 PeptiDream | JP¥2.98k | 6.2% +JP¥22.7b | 132.7% | PE22.6x | |
219A Heartseed | JP¥1.51k | 3.5% +JP¥1.1b | n/a | n/a | |
4894 Cuorips | JP¥5.17k | 2.6% +JP¥1.0b | 182.4% | PS1801.1x | |
190A Chordia Therapeutics | JP¥259.00 | 5.7% +JP¥947.5m | n/a | PB4.2x |